Agent: Umecrine Cognition Ab20110098260 - Steroid compounds and formulations: The invention provides methods to treating conditions such as prostate cancer, or for ameliorating one or more symptoms associated with prostate cancer, or for agents that modulate the biological activity of the androgen receptor.